Quest diagnostics reports second quarter 2024 financial results; raises guidance for full year 2024

Second quarter revenues of $2.40 billion, up 2.5% from 2023 second quarter reported diluted earnings per share ("eps") of $2.03, down 1.0% from 2023; and adjusted diluted eps of $2.35, up 2.2% from 2023 full year 2024 revenues now expected to be between $9.50 billion and $9.58 billion; reported diluted eps now expected to be between $7.57 and $7.77; and adjusted diluted eps expected to be between $8.80 and $9.00 secaucus, n.j. , july 23, 2024 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, today announced financial results for the second quarter ended june 30, 2024.
DGX Ratings Summary
DGX Quant Ranking